The effect of erythropoietin on lactate dehydrogenase levels during ischemia-reperfusion injury in rats

Authors

  • Constantinos Tsompos
  • Constantinos Panoulis
  • Konstantinos Toutouzas
  • George Zografos
  • Apostolos Papalois

Abstract

Objective: Aim of this experimental study was to examine the effect of erythropoietin (Epo) on a rat model and particularly in tissues by an ischemia-reperfusion (IR) protocol. The beneficial effect or non-effectiveness of that molecule were studied biochemically using mean blood lactate dehydrogenase (LDH) as a parameter of tissues’ injury.

Methods: Forty rats with a mean weight of 247.7 g were used in the study. LDH levels were measured 60 min (groups A and C) and 120 min (groups B and D) after reperfusion. Placebo drug was administered in sham operated group A and B, while Epo was administered in groups C and D. The predicted LDH values, adjusted for rats’ weight were calculated since there was a significant relation between rats’ weight and LDH levels (p= 0.0469).  

Results: Epo administration significantly increased the LDH levels by 778.3 IU/L [200.6627 IU/L - 1355.937 IU/L] (p= 0.0096). This finding was in accordance with the results of a paired t-test (p= 0.0004). Reperfusion time non-significantly decreased the LDH levels by 124.9 IU/L [-755.2258 IU/L - 505.4258 IU/L] (p= 0.6906), also in accordance with a paired t-test (p= 0.6354). Epo administration and reperfusion time together produced a significant combined effect of increasing LDH levels by 376.8 IU/L [16.55497 IU/L - 737.045 IU/L] (p= 0.0408).

Conclusion: Results of this study indicate that Epo administration alone or in interaction with reperfusion time, has increasing short – term effects on LDH levels. These increases are significant for the original LDH values and non-significant for predicted values. Considering the predicted values as more reliable, it is concluded that Epo administration declines the postischemically raised LDH levels effectively, suggesting a greater-than-expected restorating role of Epo in tissues.  

Author Biography

Constantinos Tsompos

g

References

Bakan V, Ciralik H, Tolun FI, Atli Y, Mil A, Ozturk S. Protective effect of erythropoietin on torsion/detorsion injury in rat model. J Pediatr Surg 2009;44:1988-94.

Karaca M, Odabasoglu F, Kumtepe Y, Albayrak A, Cadirci E, Keles ON. Protective effects of erythropoietin on ischemia/reperfusion injury of rat ovary. Eur J Obstet Gynecol Reprod Biol. 2009;144:157-62.

Yano T Miki T, Tanno M, Kuno A, Itoh T, Takada A, Sato T, Kouzu H, Shimamoto K,Miura T. Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. Hypertension 2011;57:110-5.

Bader A, Pavlica S, Deiwick A, Lotkova H, Kucera O, Darsow K, Bartel S, Schulze M, Lange HA, Cervinkova Z. Proteomic analysis to display the effect of low doses of erythropoietin on rat liver regeneration. Life Sci 2011;89:827-33.

Wang Q, Gorbey S, Pfister F, Höger S, Dorn-Beineke A, Krügel K, Berrone E, Wu L, Korff T, Lin J, Busch S, Reichenbach A, Feng Y, Hammes HP. Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy. Cell Physiol Biochem 2011;27:769-82.

Spriet LL, Howlett RA, Heigenhauser GJ.An enzymatic approach to lactate production in human skeletal muscle during exercise.Med Sci Sports Exerc 2000;32:756-63.

Pisarenko OI, Shulzhenko VS, Pelogeĭkina IuA, Studneva IM, Kkhatri DN, Bespalova ZhD, et al. Effects of exogenous apelin-12 on functional and metabolic recovery of isolated rat heart after ischemia. Kardiologiia 2010; 50: 44-9.

Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010; 28;122: 1308-18.

Yamagishi T, Bessho M, Yanagida S, Nishizawa K, Kusuhara M, Ohsuzu F, et al. Severe, short-term food restriction improves cardiac function following ischemia/reperfusion in perfused rat hearts. Heart Vessels 2010; 25: 417-25.

Xu C, Liu A, Sun H, Sun Y, Wang G, Gao L, et al. beta2-Adrenoceptor confers cardioprotection against hypoxia in isolated ventricular myocytes and the effects depend on estrogenic environment. J Recept Signal Transduct Res 2010; 30: 255-61.

Ciminelli M, Ascah A, Bourduas K, Burelle Y. Short term training attenuates opening of the mitochondrial permeability transition pore without affecting myocardial function following ischemia-reperfusion. Mol Cell Biochem 2006; 291: 39-47.

van der Hoeven JA, Molema G, Ter Horst GJ, Freund RL, Wiersema J, van Schilfgaarde R. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874-82.

Wang Y, Meyer JW, Ashraf M, Shull GE. Mice with a null mutation in the NHE1 Na+-H+ exchanger are resistant to cardiac ischemia-reperfusion injury. Circ Res 2003; 17;93: 776-82.

Wang WG, Deng ZS, Gong JL, Zhu Y. Protective effect of ischemic preconditioning on ischemia-reperfusion injury. Hunan Yi Ke Da Xue Xue Bao 2000; 28;25: 351-3.

Baron A, Bilzer M, Gerbes AL. Short-term treatment with mycophenolic acid increases bile flow in continuously perfused and cold-preserved rat livers and does not affect hepatic ischemia-reperfusion injury. Transpl Int 2002; 15: 265-71.

Ko KM, Mak DH, Poon MK, Yiu HY. Altered susceptibility to ischemia-reperfusion injury in isolated-perfused hearts of short-term diabetic rats associated with changes in non-enzymatic antioxidants. Jpn J Pharmacol 2001; 85: 435-42.

Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251-8.

Jaeschke H, Smith CV, Mitchell JR. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest 1988; 81: 1240-6.

Ischemia, erythropoietin, lactate dehydrogenase levels, reperfusion, restoration, tissue damage Zhou TF, Yu JG. Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia. J Surg Res 2013 ; 183: 304-12.

Pottgiesser T, Garvican LA, Martin DT, Featonby JM, Gore CJ, Schumacher YO. Short-term hematological effects upon completion of a four-week simulated altitude camp. Int J Sports Physiol Perform 2012; 7: 79-83.

Dulaney JT, Hatch FE Jr, Young J. Effect of amines on erythropoietin-stimulated heme synthesis in fetal mouse liver cells. Life Sci 1985; 29;36: 1633-42.

Downloads

Published

10.04.2014

Issue

Section

Original Research